Study Design. Human ligamentum fl avum (LF)-derived stem cells (LFSCs) and nucleus pulposus cells (NPCs) were cocultured under normoxia or hypoxia. Objective. To isolate and identify human LFSCs and determine whether they can differentiate into NPCs when cocultured with NPCs under hypoxia. Summary of Background Data. Mesenchymal stem cell (MSC)-based therapies have been proposed as a biological treatment for intervertebral disc degeneration. MSCs derived from various tissues are leading candidates for cell-based therapies, but such cells have not been reported in LF. Methods. LF cells were isolated from patient samples and cultured using culture fl asks coated with fi bronectin, and their identity was confi rmed using fl ow cytometry. The cells were induced to differentiate into osteoblasts, chondrocytes, and adipocytes, and their morphology, immunophenotype, cell proliferation capacity, cell cycle, and expression of stem cell-specifi c genes were compared with those of bone marrow-MSCs (BM-MSCs) derived from the same patients. NPCs and LFSCs were cocultured in 1-μ mpore-size insert transwell-culture systems under hypoxia (2% O 2 ) or normoxia. CD24 expression was measured by fl ow cytometry and confocal microscopy assay. On day 14, reverse transcriptionpolymerase chain reaction was used for comparing the expression of The manuscript submitted does not contain information about medical device(s)/drug(s).
I
ntervertebral disc (IVD) degeneration is closely related to low back pain, 1 which is experienced in around 40% of patients with back pain. 2 IVD degeneration involves a reduction in the function and number of viable cells in the disc, mostly through cellular senescence 3 and apoptosis, 4 , 5 and this is accompanied by diminished synthesis of extracellular matrix components such as collagens and proteoglycans and a reduction of the water content. Current IVD degeneration treatments mainly involve drug application and surgery, which is limited to relieve symptoms. However, in cell-based tissue engineering, the aim is to restore IVD structure and function. In clinical trials, pain was reduced in patients treated with disc-chondrocyte transplantation, 6 and in osteoarthritis treatment, implantation of autologous chondrocytes and matrix-induced autologous chondrocytes yielded favorable results. 7 Researchers aim to use a similar strategy in treating IVD degeneration and have previously E666 www.spinejournal.com June 2015 demonstrated the proliferative capacity and pluripotency of mesenchymal stem cells (MSCs), whose transplantation is considered a promising approach in developing new treatments of IVD degeneration. Several types of multipotent stem cells are present in adult tissues (such as in bone marrow, heart, brain, skeletal muscle, adipose tissues, synovial membrane, and menstrual blood 8 ) , and MSCs show similar characteristics such as multigenerational propagation, selfrenewal, multilineage differentiation, and specifi c phenotypes. However, most MSCs are obtained with diffi cultly or invasively.
Current transforaminal endoscopic surgery and microendoscopic discectomy pass through ligamentum fl avum (LF), which has been widely suggested to contain multipotent stem cells. 9 However, no study has identifi ed a defi nitive stem/progenitor-cell population in LF. We tested whether stem cells present in LF (LF-derived stem cells; LFSCs) can be induced into nucleus pulposus cells (NPCs) in vitro . We isolated a rare cell population from human LF and showed that they exhibit several universal stem cell properties. Previously, methods such as hypoxia treatment, use of 3-dimensional scaffolds, and coculturing were employed to induce MSCs' differentiation into NP-like cells. [10] [11] [12] [13] Here, we used hypoxia and a 3D coculture system to test whether LFSCs can differentiate into NP-like cells. Coculturing with NPCs potently induced chondrogenic differentiation, as shown by the upregulated expression of collagen-II, aggrecan, and Sox-9.
14 After differentiation, human NP-specifi c markers were also detected, such as CD24, cytokeratin-19 (KRT19), carbonic anhydrase XII (CA12), and forkhead box F1 (FOXF1) 15 ; all these genes were upregulated when LFSCs were cocultured with NPCs. The use of autologous stem cells is regarded to be ethically appropriate, and we suggest that LFSCs could emerge as new seed cells for treating IVD degeneration.
MATERIALS AND METHODS

Cell Culture
LF tissue (3-5 g) was obtained from patients who underwent transforaminal endoscopic surgery for lumbar degenerative disease ( Table 1 ) for obtaining a high yield. Cells were cultured in α -minimum essential medium ( α -MEM) supplemented with 16.6% fetal bovine serum and 100 U/mL penicillin-streptomycin for 12 hours at 37 ° C in 5% CO 2 ; the medium was changed twice weekly. Passage 3 was transferred to culture fl asks coated with fi bronectin (5 µg/cm 2 ) as described previously. LFSCs were positive for CD90, CD29, CD44, CD73, and CD105, and negative for STRO-1, CD34, CD45, and CD133, which were examined by an FACScan fl ow cytometer running CellQuest software (Beckman Coulter, Brea, CA) (see Supplemental Digital Content 3, Figure samples were isolated and grown as described previously and used at Passage 3.
Testing LFSC Multipotency
Osteogenic Differentiation Cells were incubated for 21 days in an osteogenic medium containing 10% fetal calf serum (FCS; Hyclone Laboratories, Inc., Logan, UT), 10 nmol/L dexamethasone, 10 mmol/L β -glycerophosphate, and 0.1 mmol/L l-ascorbic acid-2-phosphate; control cells were maintained in α -MEM/10% FCS. Media were changed twice weekly. Mineral deposits were identifi ed using alizarin-red staining.
Adipogenic Differentiation
Cells were incubated for 72 hours in an induction medium containing 10 μ g/mL insulin, 1 μ mol/L dexamethasone, 500 μ mol/L 3-isobutyl-1-methyl xanthine, and 100 μ mol/L indomethacin, and then for 24 hours in a maintenance medium (10 μ g/mL insulin in α -MEM/10% FCS). This 96-hour treatment cycle was repeated 5 times and then cultures were incubated in the maintenance medium until 30 days. Control cells were maintained in DMEM/F12/10% FCS. Lipid droplets were stained with Oil Red O.
Chondrogenic Differentiation
We used the micromass-culture method; to generate micromass cultures, we placed 20-μ L droplets of cell suspensions (in cell-culture medium; 2.5 × 10 5 cells) in the center of multiwell-plate wells and after culturing for 2 hours under high humidity, we added a chondrogenic-differentiation basal medium (dexamethasone, ascorbate, ITS-Premix (BectonDeck-inson), sodium pyruvate, proline, and transforming growth factor (TGF)-β 3) to the culture vessels and incubated them up to 21 days. The micromass cultures were fi xed and stained with 1% Alcian blue.
LFSCs-NPCs Coculture
We used 6-well coculture plates consisting of 1-μ m-pore-size, high-pore-density, 3D polyethylene terephthalate track-etched tissue-culture inserts. Passage-3 LFSCs and NPCs were cocultured to allow direct contact between the cells, as described. 17 Briefl y, 5 × 10 4 NPCs were cultured on the reverse side of the membrane inserts for 12 hours, and after their adhesion, the inserts were turned upright and LFSCs at the same density were cultured on the front side ( Table 2 ) , respectively, for 14 days under 2%-O 2 or 20%-O 2 (normal) tension. We used hypoxia to induce LFSC differentiation because the native NPtissue environment is hypoxic, and hypoxia represents a critical environmental factor that promotes MSC differentiation. 10 The control was non-cocultured LFSCs; Table 2 lists groups used in this study. After coculture, LFSC morphology changes were examined. To denote a nucleus pulposus-like differentiation phenotype, the CD24-FITC (Santa Cruz Biotechnology, Inc., Dallas, TX)-labeled cells were analyzed using an FACScan fl ow cytometer running CellQuest software (Beckman Coulter, Brea, CA). To detect CD24 were located in differentiated and undifferentiated LFSCs after 14 days and 21 days of coculture, which were methanol-fi xed and incubated with CD24-FITC (mouse, 1:100, Santa Cruz Biotechnology, Inc., Dallas, TX) for 3 hours at 4 ° C, then washed, visualized with a Leica confocal microscope.
Real-Time/Reverse Transcription-Polymerase Chain Reaction Analysis
We used reverse transcription-polymerase chain reaction (RT-PCR) to evaluate the expression of differentiation-related genes ( ALP , OC , RUNX-2 ; PPAR-2 , APP , LPL ; and AGG , COL II , Sox-9 ), and real-time PCR for testing stem cellspecifi c genes ( NANOG , Sox-2 , and OCT-4 ) and extracellular matrix or the characteristic NP markers (HIF-1 α , Sox-9, collagen-II, aggrecan, KRT19, FOXF1, and CA12). After 2 weeks of coculture, LFSCs were isolated by trypsin from each group. Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Concentration of total RNA was determined with a spectrophotometer (DU-500; Beckman, Fullerton, CA) at 260-nm wavelength. Two micrograms of total RNA were used to synthesize cDNA (MBI Fermantas, Sankt Leon-Rot, Germany). For RT-PCR, 1 mL of cDNA template was used for each reaction and sequences were amplifi ed using Taq DNA polymerase. Differentiation related gene primers were designed and synthesized as shown in Table 3 . β -actin was used to normalize the reactions. For Quantitative Reverse Transcription Polymerase Chain, Reaction Analysis Reactions (20 μ L) including 10 μ L of Sybr Green (BIO-RAD), 2 μ L of DNA, 1 μ L of each primer, and 6 μ L of sterile distilled water were performed in triplicates with C1000 Touch Thermal Cycler (BIO-RAD) for PCR amplifi cation. Target gene expression was calculated by the 2 − Δ Δ Ct method and normalized to β -actin and control. Differential expression was examined using 1-factor analysis of variance and was considered signifi cantly different at P value of less than 0.05. The primers used are shown in Tables 4. was verifi ed on the basis of the deposition of an alizarin-redpositive mineralized matrix at 3 weeks after induction (Figure 2a B) ; this was not observed in control cells (Figure 2a  E) . Chondrogenic differentiation was confi rmed on the basis of Alcian blue staining, which revealed glycosaminoglycan deposition (Figure 2a C) , and in the growth culture, no cells stained positively for Alcian blue (Figure 2a F) .
PCR for Differentiation-and Stem Cell-Related Gene Expression
RT-PCR results showed that all induction-related genes ( ALP , OC , RUNX-2 ; PPAR-2 , APP , LPL ; and AGG , COL II , Sox-9 ) were expressed at higher levels in the 3 induction groups than in the control group (Figure 2b A-C). Compared with BM-MSCs, LFSCs expressed higher levels of NANOG, Sox-2, and OCT-4 ( Figure 3) . The results were confi rmed using real-time RT-PCR. LFSCs and BM-MSCs did not express signifi cantly different levels of NANOG and Sox2 (2-tailed, t = 0.37, P = 0.68, and t = 1.83, P = 0.22, respectively); however, the OCT4 mRNA level was higher in LFSCs than in BM-MSCs (2-tailed, t = 12.8, P = 0.004). In LFSCs, sox2, NANOG, and OCT4 mRNAs were measured to be (mean ± SD) 300.40 ± 71,125 ± 226, and 83 ± 6.9 fg/mg, respectively, and in BM-MSCs, these were 298.45 ± 61,118 ± 7, and 42.5 ± 1.8 fg/mg, respectively. 
Genes Expression After Coculture
To explore the Expression of CD24 during differentiation of Human LFSCs, we examined its expression pattern by confocal microscopy assay and fl ow cytometry. Regarding the confocal microscopy assay, the results revealed that there were a large number of cells that expressed CD24 in the differentiated LFSCs. This indicated that LFSCs have some potential to differentiate into cells sharing features with the phenotype of the healthy NP cell. Levels of CD24 expression were consistent with the immunostaining pattern, compared with undifferentiated group (Figure 4A ), which was highly signifi cant ( P < 0.001) ( Figure 4B ). The CD24 expression of undifferentiated group (45.9%, Figure 4C ) was lower than differentiated (82.8%, Figure 4D ). For quantitative analysis in differentiated LFSCs and undifferentiated, the former CD24 level was higher than the latter after 14 days and 21 days of coculture ( Figure 4E ) ( P < 0.05). PCR analysis of NP-marker expression in differentiated LFSCs showed that after 14 days of coculture, the expression of the following genes was signifi cantly increased relative to control ( P < 0.05) in both normoxic-and hypoxic-group cells ( Figure 5 ): KRT19 (A), CA12 (C), ACAN (D), COL2A1 (E), Sox-9 (F), and HIF-1 α (G). However, under hypoxia, FOXF1 (B) was not upregulated.
DISCUSSION
The tissue-resident adult stem/progenitor cells are unique compared with other embryonic/umbilical cord/fetal/placentalderived stem cell sources in that they are enriched in a readily accessible anatomical location. Bone marrow-derived stromal cells constitute 0.125% of the total marrow cells. However, we identifi ed a large LFSC subpopulation and isolated these cells from LF. LF tissue is an abundant, accessible, and replenishable source of adult stem cells. LFSCs coexpress MSC markers such as CD90 and CD105, which were detected in 2.17% to 3.25% of the total cell mass. We found that 1 to 3 g of tissue is required for expanding the isolated cells. The use of ex vivo -expanded adult stem/progenitor cells and their differentiated progenies offers great promise for cellreplacement therapies with multiple applications in humans. Moreover, the chondrogenesis induction observed highlights the robustness of the described biological phenomenon and suggests that alternative cell sources, which can be harvested under minimally invasive conditions, might be considered for clinical implementation of the described paradigms. Because LFSCs have been poorly characterized and their specifi c markers remain unidentifi ed, we sought to identify stem cells in human LF and evaluate their potential to differentiate into NP-like cells in vitro . Using the fi bronectin differentialadhesion assay, we obtained homogeneous LFSCs, our results provided evidence that LSCs on FN induced a higher rate of migration than on a glass surface. Migration of cells is facilitated by the adhesive interaction of cells with the substrate, which is determined by specifi c integrin-ligand binding affi nity, level of ligands, generation of forces at binding sites. as demonstrated using fl ow cytometry, the proliferation rate, cell cycle, and RT-PCR. Recently, primary fi broblast-like cells derived from diverse human tissues were shown to be capable of differentiating into at least 1 mesenchymal lineage. 18 Although LFSCs and BM-MSCs expressed many of the same markers, the expression patterns were not identical. LFSCs highly expressed CD90, CD29, CD44, CD73, and CD105 but not the BM-MSC-marker stro-1; although not mentioned in the International Society for Cellular Therapy's (ISCT) criteria as a suitable marker to identify multipotent cells, 19 stro-1 might serve a selective negative marker for LFSCs. LFSCs could also differentiate into osteoblasts, adipocytes, and chondrocytes. To further confi rmed the unique phenotype of the isolated LFSCs. We also used Immunocytochemistry staining. Specifi cally, all LFSCs expressed highly expressed a-SMA, type I collagen, and fi bronectin, but not expressed type II collagen (Supplemental Digital Content, Figure 6 available at: http:// links.lww.com/BRS/A995). LFSCs and BM-MSCs expressed the same stem cell-related genes ( OCT-4 , NANOG , and Sox-2 ), and OCT-4 amplifi cations were signifi cantly detected in LFSCs. These genes are required for effi cient self-renewal of embryonic stem cells, Tai et al 20 have shown that OCT-4 is expressed in several adult human stem cells. The inductionrelated genes were markedly upregulated in the respective induction groups. We have also compared the morphology, proliferation potential, and cell cycle of LFSCs with those of BM-MSCs from the same subjects. These data suggest that LFSCs are closely related-but not identical-to BM-MSCs.
We sought to test whether LFSCs can be used to overcome a shortage of seed cells required for disc regeneration. To date, studies have applied methods commonly used to induce chondrogenesis and have reported that 2%-O 2 tension promoted the differentiation of human BM-MSCs into NP-like cells. 21 Here, we used the transwell system, which facilitates close cell-cell contact and is a widely accepted 3D cultivation system; in this system, hypoxia induced LFSC differentiation into NP-like cells that synthesized an extracellular matrix similar to that synthesized by NPCs. In these transwells, 2 types of cells are adhered to 2 sides of porous membranes, and this coculture method enables direct contact between the 2 types of cells through extended cytoplasmic processes. Recently, the Spine Research Interest Group made the recommendation of the following healthy NP phenotypic markers: stabilized expression of HIF-1a, GLUT-1, aggrecan/collagen II ratio greater than 20, Shh, Brachyury, KRT18/19, CA12, and CD24. 22 In our study, We predicted that LFSCs have the potential to differentiate into cells sharing features with populations of NP progenitor cells or immature NP morphology that are CD24 robustly positive. This indicated that LFSCs have some potential to differentiate into cells sharing features with the phenotype of the healthy NP cell. We also examined NP-specifi c markers HIF-1 α , Sox-9, collagen-II, aggrecan, KRT19, FOXF1, and CA12. HIF-1 α is a crucial mediator of the adaptive response of cells to hypoxia, which is essential for the growth and survival of growth-plate chondrocytes in vivo , 23 but HIF-1 α is also robustly expressed under normoxic culture conditions. 24 Sox-9 is expressed in all chondrocyte progenitors and chondrocytes, 25 and this is required for chondrocyte differentiation, cartilage formation, and expression of chondrocyte-marker genes such as Col2a and aggrecan . 26 The collagen-II gene is an early and abundant chondrocytedifferentiation marker. Keratins comprise the largest subfamily of intermediate-fi lament proteins and provide structural support to the nucleus and tensile strength to the cell. 27 Lee et al 28 identifi ed KRT19 as an NP-marker gene that is highly differentially expressed, and Sakai et al 29 performed comparative microarray analysis on KRT19 . FOXF1 has been poorly studied, but recent fi ndings have revealed its nonrandom association with birth defects such as spinal malformations and vertebral fusion. 30 Recently, Dahia et al 31 reported that hypoxia induced Sonic hedgehog signaling, which is required for IVD differentiation, but we found that FOXF1 expression did not differ between hypoxia and normoxia groups. CA12 is potentially related to NPCs' adaptation to their harsh niche; 32 its identifi cation in hypoxic NPCs might refl ect the use of a similar homeostatic mechanism under hypoxia. 33 , 34 CA12 also maintains acid-base equilibrium by transporting CO 2 from cells residing in acidic environments 35 ; thus, acidbase physiology could play a crucial role in NP-like cell survival and function in the IVD. Although no complete set of markers has yet been established for NP cells, fi ndings of this study suggest that LFSCs may be induced to differentiate into NP-like cells as demonstrated by the presence of multiple NPassociated markers.
In summary, LFSCs are favorable cell-therapy candidates because they can be accessed readily, they proliferate rapidly, and obtaining them causes limited donor-site morbidity. Here, we identifi ed certain LFSC-specifi c markers and demonstrated that LFSCs were successfully differentiated into NP-like cells, which produced an extracellular matrix similar to that of NPCs and expressed characteristic NP markers. Moreover, hypoxia enhanced the expression of these NP markers in differentiated LFSCs. Furthermore, using an injectable hydrogel to deliver cells to the injured disc might minimize the surgical risk of transplantation. To fully harness LFSCs' potential for IVD regeneration, an appropriate vehicle is required to facilitate effective LFSC delivery into the disc and additionally provide an optimized environment for tissue regeneration once the cells are in situ, and LFSCs can be expanded in vitro in suffi cient quantities for tissue engineering. Although expanding LFSCs is less straightforward than originally expected, several approaches have been used for this purpose, including the development of specialized media, coculture with other cell types, identifi cation and use of growth factors that exert proliferative effects on LFSCs, and culture on 3D scaffolds within bioreactors that simulate the in vivo environment. The optimal material used for IVD treatment must be injectable, nonantigenic, nonmigratory, volume-stable, and safe for human use.
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➢ Key Points
This study identifi es the presence of stem cells in the human ligamentum fl avum. Ligamentum fl avum-derived stem cell have some specifi c markers, such as negative of STRO-1, highly expressed a-SMA, type I collagen, and fi bronectin. (Supplemental Digital Content, Figure 6 , available at:) Real-time PCR shows that the LFSCs upregulate the expression of Sox-9, type II collagen, aggrecan, KRT19, CA12, and HIF-1 α but not FOXF1 .
LFSCs were successfully diff erentiated into NPlike cells, which could provide new cell candidates for cell-based regenerative medicine and tissue engineering. Ligamentum fl avum is thought to be better candidate for cell therapy because of its ease of access, limited donor-site morbidity, and high proliferation rate.
